· Original article
Talzenna approval expands Pfizer’s prostate cancer treatment
Talzenna approval expands Pfizer’s prostate cancer combination to a genetically defined metastatic group, supported by the Phase 3 TALAPRO-3 trial.
FINANCEVELIX / News
Equities & companies · Page 151
Equities & companies
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
My news topics
My news topics →Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Equities & companies
RSSResults: 3,834 · Page 151 / 320
· Original article
Welltower shares slip after Q3 miss despite higher outlook
Welltower shares fell 1.29% after hours as Q3 earnings and revenue missed estimates, while senior housing growth supported higher 2026 guidance.
· Original article
US stocks rise in early trading as Anthropic IPO draws focus
US stocks advanced in early trading on October 26 as investors assessed Anthropic’s proposed IPO and awaited major technology earnings and the Fed.
· Original article
Nebius stock falls 5.18% after Musk's AI debt warning
Nebius stock fell to $150.52 on October 26 after Elon Musk warned about AI cloud financing, days after Nebius secured a $3.5 billion Citi facility.
· Original article
CityScape collaboration extended for three years by Marsh Re
Synthetik and Marsh Re extend their CityScape collaboration for three years, covering multi-peril consultancy and urban explosion-risk modelling.
· Original article
Onco360 pharmacy partnership adds Zegfrovy cancer treatment
The Onco360 pharmacy partnership with AstraZeneca covers Zegfrovy, a targeted lung cancer treatment, with patient access and support central to its role.
· Original article
CEFC earnings slip as higher costs outweigh interest gains
CEFC earnings fell in the third quarter of 2026 as higher operating costs outweighed net interest income growth, while securities holdings expanded.
· Original article
Commercial Bank earnings fall as higher provisions offset growth
Commercial Bank earnings fell 13.8% in the first nine months of 2026 as provisions rose, while management warned of fourth-quarter margin pressure.
· Original article
Adani Power earnings: Q2 FY27 profit jumps 141.5%
Adani Power earnings rose sharply in Q2 FY27, helped by stronger power sales and one-time revenue, while higher coal costs limited core profit growth.
· Original article
Indian IT revenue: Europe outpaces North America in Q2 FY27
Indian IT revenue growth favored Europe over North America in Q2 FY27, though HCLTech bucked the trend as selective US spending weighed on demand.
· Original article
Carpenter Technology cut to Sector Weight by KeyBanc
Carpenter Technology was downgraded by KeyBanc on near-term earnings concerns, while the company maintained its fiscal 2027 operating-income outlook.
· Original article
Anthropic IPO filing leaves price and share count undecided
Anthropic IPO plans target Nasdaq under ANT, but pricing remains unset as rapid revenue growth sits alongside large losses and cloud-partner exposure.
Charts and market data by TradingView. Availability and delays vary by exchange.